{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:13:33Z","timestamp":1783440813803,"version":"3.54.6"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/tp.0000000000000487","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T12:58:26Z","timestamp":1417006706000},"page":"1220-1225","source":"Crossref","is-referenced-by-count":22,"title":["Human Leukocyte Antigen Type and Posttransplant Lymphoproliferative Disorder"],"prefix":"10.1097","volume":"99","author":[{"given":"Mark E.","family":"Lustberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley I.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Quinion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Caligiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.tp.0000269617.60751.c4","article-title":"Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.","volume":"84","author":"Babel","year":"2007","journal-title":"Transplantation"},{"key":"R2-23-20210129","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"R3-23-20210129","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"key":"R4-23-20210129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.20795","article-title":"Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.","volume":"82","author":"Buadi","year":"2007","journal-title":"Am J Hematol"},{"key":"R5-23-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.1995.13.4.961","article-title":"Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.","volume":"13","author":"Leblond","year":"1995","journal-title":"J Clin Oncol"},{"key":"R6-23-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1997.tb00813.x","article-title":"Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era.","volume":"11","author":"Ciancio","year":"1997","journal-title":"Clin Transplant"},{"key":"R7-23-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/jcp.56.6.439","article-title":"Lymphoproliferative disorders in Oxford renal transplant recipients.","volume":"56","author":"Bates","year":"2003","journal-title":"J Clin Pathol"},{"key":"R8-23-20210129","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"R9-23-20210129","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2012.43.2344","article-title":"Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.","volume":"31","author":"Caillard","year":"2013","journal-title":"J Clin Oncol"},{"key":"R10-23-20210129","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders.","volume":"38","author":"Rezk","year":"2007","journal-title":"Hum Pathol"},{"key":"R11-23-20210129","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitts lymphoma.","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"R12-23-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(64)92354-2","article-title":"Cultivation in vitro of human lymphoblasts from Burkitts malignant lymphoma.","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"R13-23-20210129","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","article-title":"The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.","volume":"110","author":"Park","year":"2007","journal-title":"Blood"},{"key":"R14-23-20210129","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045","article-title":"Epstein-Barr virus genome in non-Hodgkins lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.","volume":"87","author":"dAmore F, Johansen","year":"1996","journal-title":"Blood"},{"key":"R15-23-20210129","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.1969.03160090035008","article-title":"Prevalence of antibodies to EB virus and other herpesviruses.","volume":"208","author":"Porter","year":"1969","journal-title":"JAMA"},{"key":"R16-23-20210129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1073\/pnas.63.3.740","article-title":"Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures.","volume":"63","author":"Gerber","year":"1969","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-23-20210129","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":"Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"key":"R19-23-20210129","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00277-007-0298-2","article-title":"Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.","volume":"86","author":"Choquet","year":"2007","journal-title":"Ann Hematol"},{"key":"R20-23-20210129","first-page":"1059","article-title":"The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.","volume":"91","author":"Sundin","year":"2006","journal-title":"Haematologica"},{"key":"R21-23-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(94)90043-4","article-title":"Clinical characteristics of post-transplant lymphoproliferative disorders.","volume":"97","author":"Morrison","year":"1994","journal-title":"Am J Med"},{"key":"R22-23-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report.","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"R23-23-20210129","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2009-02-202507","article-title":"Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.","volume":"114","author":"van Leeuwen","year":"2009","journal-title":"Blood"},{"key":"R24-23-20210129","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0041-1345(00)02700-7","article-title":"A gene polymorphism associated with posttransplant lymphoproliferative disorder.","volume":"33","author":"VanBuskirk","year":"2001","journal-title":"Transplant Proc"},{"key":"R25-23-20210129","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood-2003-07-2476","article-title":"IFN-gamma gene polymorphisms associate with development of EBV lymphoproliferative disease in hu PBL-SCID mice.","volume":"105","author":"Dierksheide","year":"2005","journal-title":"Blood"},{"key":"R26-23-20210129","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1399-0012.2006.00498.x","article-title":"Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.","volume":"20","author":"Lee","year":"2006","journal-title":"Clin Transplant"},{"key":"R27-23-20210129","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2005.05875.x","article-title":"The presence of IFNG 33 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation.","volume":"132","author":"Bogunia-Kubik","year":"2006","journal-title":"Br J Haematol"},{"key":"R28-23-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1523-1755.2004.00749.x","article-title":"Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants.","volume":"66","author":"Babel","year":"2004","journal-title":"Kidney Int"},{"key":"R29-23-20210129","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.bjc.6605278","article-title":"Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.","volume":"101","author":"McAulay","year":"2009","journal-title":"Br J Cancer"},{"key":"R30-23-20210129","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1164\/rccm.200804-531OC","article-title":"Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.","volume":"178","author":"Wheless","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-23-20210129","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0039-6060(96)80265-0","article-title":"Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation.","volume":"119","author":"Montone","year":"1996","journal-title":"Surgery"},{"key":"R32-23-20210129","first-page":"16","article-title":"Associations of Human Leukocyte Antigen (HLA) haplotypes with risk of developing lymphoproliferative disorders after renal transplantation.","volume":"12","author":"Pourfarziani","year":"2007","journal-title":"Ann Transplant"},{"key":"R33-23-20210129","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.0915054107","article-title":"HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.","volume":"107","author":"Hjalgrim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-23-20210129","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2008-06-162883","article-title":"A mechanism for the HLA-A01-associated risk for EBV Hodgkin lymphoma and infectious mononucleosis.","volume":"112","author":"Brennan","year":"2008","journal-title":"Blood"},{"key":"R35-23-20210129","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A02 is associated with a reduced risk and HLA-A01 with an increased risk of developing EBV Hodgkin lymphoma.","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"},{"key":"R36-23-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/QAI.0b013e3181b017d5","article-title":"The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkins lymphoma.","volume":"52","author":"Aissani","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R38-23-20210129","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.tp.0000235889.05171.12","article-title":"Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation.","volume":"82","author":"Subklewe","year":"2006","journal-title":"Transplantation"},{"key":"R39-23-20210129","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1600-6143.2011.03454.x","article-title":"Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant"},{"key":"R40-23-20210129","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0002-9440(10)65193-0","article-title":"Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations.","volume":"155","author":"Chu","year":"1999","journal-title":"Am J Pathol"},{"key":"R41-23-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.7682013","article-title":"HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11 population.","volume":"260","author":"de Campos-Lima PO, Gavioli","year":"1993","journal-title":"Science"},{"key":"R42-23-20210129","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1128\/JVI.77.21.11507-11516.2003","article-title":"HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.","volume":"77","author":"Midgley","year":"2003","journal-title":"J Virol"},{"key":"R43-23-20210129","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1086\/587848","article-title":"Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response.","volume":"197","author":"Bell","year":"2008","journal-title":"J Infect Dis"},{"key":"R44-23-20210129","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI32377","article-title":"HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.","volume":"117","author":"McAulay","year":"2007","journal-title":"J Clin Invest"},{"key":"R45-23-20210129","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/j.transproceed.2009.04.017","article-title":"Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.","volume":"41","author":"Kekik","year":"2009","journal-title":"Transplant Proc"},{"key":"R46-23-20210129","first-page":"456","article-title":"Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan.","volume":"57","author":"Tseng","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"R47-23-20210129","first-page":"68","article-title":"Human leukocyte antigen class I alleles can predict response to pegylated interferonribavirin therapy in chronic hepatitis C Egyptian patients.","volume":"16","author":"Farag","year":"2013","journal-title":"Arch Iran Med"},{"key":"R48-23-20210129","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.antiviral.2009.11.006","article-title":"Human leukocyte antigen alleles and the response to pegylated interferonribavirin therapy in chronic hepatitis C patients.","volume":"85","author":"Dai","year":"2010","journal-title":"Antiviral Res"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:11:03Z","timestamp":1747170663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201506000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000487","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}